MedPath

Prospective Trial on the Clinical Feasibility of a New Full Thickness Endoscopic Plication Device for Patients With GERD.

Not Applicable
Completed
Conditions
Gastroesophageal Reflux Disease
Interventions
Procedure: endoscopic full thickness plication
Registration Number
NCT01798212
Lead Sponsor
Krankenhaus Barmherzige Schwestern Linz
Brief Summary

A prospective multi center case controlled trial on the clinical feasibility of a new full thickness endoscopic plication device for patients with GERD.

The primary objective of the present trial is to investigate, clinical feasibility of the GERDx™ device, evaluating surgical aspects, quality of life, and symptom sores. Secondary objective of the trail is to evaluate objective data before and after the procedure, using manometry and 24h impedeance measurement

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria

Written informed consent; ≥ 18 years of age;

GERD documented by 24h ambulatory Multichannel Impedance-pH-Monitoring off antisecretory therapy and/or Gastroscopy by one or more of the following criteria:

  • Total Number of Reflux Events ≥ 73/24h;
  • DeMeester Score ≥ 14.7;
  • Positive Symptom Index - SI ≥ 50% for Symptoms troublesome for the Patient with a Frequency of at least 3/24hrs; Macroendoscopically distinct mucosal breaks.
Exclusion Criteria

Patients with known immunological dysfunction (advanced liver disease, HIV, hepatitis C virus infection), drug addiction;

≤ 18 years of age; Pregnancy and lactation; Previous extensive abdominal surgery; Previous esophageal or gastric surgery; Hiatal hernia >2cm; paraesophageal hernia; American Society of Anaesthesiologists physical status classification >II

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
full thickness gastroplicationendoscopic full thickness plication-
Primary Outcome Measures
NameTimeMethod
Quality of Life using the Gastrointestinal Quality of Life Indexchange from baseline in Quality of Life at 3 months, one year and three years after the intervation
Secondary Outcome Measures
NameTimeMethod
lower esophageal sphincter pressure using oesophageal manometrychange from baseline in lower esophageal sphincter pressure at 3 months, one year and 3 years after the intervantion
DeMeester score, number of reflux events using 24h-ph-Impedancemeasurmentchange from baseline in DeMeester score at 3 months, one year and 3 years after the intervantion

Trial Locations

Locations (2)

Krankenhaus Zell am See

🇦🇹

Zell am See, Austria

Krankenhaus Barmherzige Schwestern

🇦🇹

Linz, Austria

© Copyright 2025. All Rights Reserved by MedPath